Published in Am J Cardiol on March 01, 1977
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Blood pressure in a national birth cohort at the age of 36 related to social and familial factors, smoking, and body mass. Br Med J (Clin Res Ed) (1985) 3.39
Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care. CMAJ (1999) 1.90
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci (2011) 1.74
Weight penalties. Br Med J (1979) 1.51
Risk factors and progression of atherosclerosis in youth. PDAY Research Group. Pathological Determinants of Atherosclerosis in Youth. Am J Pathol (1998) 1.48
The experimental evidence for weight-loss treatment of essential hypertension: a critical review. Am J Public Health (1982) 1.41
Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.05
Body weight and risk of myocardial infarction and death in the adult population of eastern Finland. Br Med J (Clin Res Ed) (1987) 1.01
The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nat Clin Pract Cardiovasc Med (2009) 0.97
The electrocardiogram in apparently healthy men and the risk of sudden death. Br Heart J (1982) 0.95
Targeting progress in health. Public Health Rep (1982) 0.95
Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. J Clin Invest (1987) 0.93
The prevalence of obesity and obesity-related health conditions in a large, multiethnic cohort of young adults in California. Ann Epidemiol (2012) 0.92
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circ Res (2016) 0.89
Natural history of left bundle-branch block. Br Heart J (1980) 0.89
Laparoscopic cholecystectomy in the grossly obese: 4 years experience and review of literature. HPB (Oxford) (2002) 0.89
Skinfold thickness, body mass index and ischaemic heart disease. J Epidemiol Community Health (1989) 0.89
A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J Lipid Res (2014) 0.88
Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J Transl Med (2012) 0.87
Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects. Br Med J (1980) 0.86
Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J (2009) 0.85
The association between "hypertriglyceridemic waist" and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional study. Lipids Health Dis (2014) 0.84
Electrocardiographic abnormalities in apparently healthy men and the risk of sudden death. Drugs (1984) 0.81
Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels (2011) 0.80
Body composition indices and predicted cardiovascular disease risk profile among urban dwellers in Malaysia. Biomed Res Int (2015) 0.79
Relationship between obesity and coronary heart disease among urban Bangladeshi men and women. Integr Obes Diabetes (2015) 0.78
Human obesity. Exploding the myths. West J Med (1990) 0.78
Resting energy expenditure in moderate obesity. Predicting velocity of weight loss. Ann Surg (1986) 0.76
Modeling the shape and composition of the human body using dual energy X-ray absorptiometry images. PLoS One (2017) 0.75
Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies. Int J Obes (Lond) (2015) 0.75
Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada. Cardiol Res Pract (2016) 0.75
Does body mass index misclassify physically active young men. Prev Med Rep (2015) 0.75
Venous thromboembolic disease in uncemented total hip replacement surgery--a one-year follow-up of 490 patients. J R Soc Med (1991) 0.75
Review Of Obesity And Atrial Fibrillation: Exploring The Paradox. J Atr Fibrillation (2015) 0.75
The Relationship between Body Mass Index and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography. Cardiol Res Pract (2017) 0.75
Obesity in a Somerset town: prevalence and relationship to morbidity. J R Coll Gen Pract (1984) 0.75
Obesity and coronary artery calcification: Can it explain the obesity-paradox? Int J Cardiovasc Imaging (2015) 0.75
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ (1997) 2.41
Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med (1999) 1.87
The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ (1997) 1.61
Hyperkalemia-induced bundle branch block and complete heart block. Clin Cardiol (1981) 1.35
Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ (1993) 1.32
Chronobiology of cardiac sudden death in men. JAMA (1980) 1.30
The natural history of primary first-degree atrioventricular heart block. N Engl J Med (1986) 1.23
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor. J Exp Med (1991) 1.18
The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study. Ann Intern Med (1992) 1.15
Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci (1994) 1.12
Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. J Biol Chem (1998) 1.09
Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.05
Cytosolic free magnesium in cardiac myocytes: identification of a Mg2+ influx pathway. Biochem Biophys Res Commun (1990) 1.04
A model of cardiac arrhythmias and sudden death: cantharidin-induced toxic cardiomyopathy. J Pharmacol Exp Ther (1979) 1.03
Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Intern Med (1978) 1.03
Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim Biophys Acta (2000) 1.02
Relative role of factors associated with cerebral infarction and cerebral hemorrhage. A matched pair case-control study. Stroke (1977) 1.01
Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod Pathol (1997) 1.00
An Apparent Instance of Parathormone Inactivity. Can Med Assoc J (1937) 0.99
Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens (1999) 0.97
Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation (2001) 0.97
Dynamics of intracellular free Mg2+ changes in a vascular smooth muscle cell line. Am J Physiol (1993) 0.96
The electrocardiogram in apparently healthy men and the risk of sudden death. Br Heart J (1982) 0.95
Chromosome-specific aneusomy in carcinoma of the breast. Clin Cancer Res (1996) 0.93
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ (1997) 0.90
The relation of blood pressure to stroke prognosis. Ann Intern Med (1978) 0.90
Preoperative electrocardiography effect of new abnormalities on clinical decisions. Can Med Assoc J (1983) 0.90
Relationship of ventricular ectopy in men without apparent heart disease to occurrence of ischemic heart disease and sudden death. Am Heart J (1981) 0.90
Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660). Clin Genet (2007) 0.89
Preoperative electrocardiography: its cost-effectiveness in detecting abnormalities when a previous tracing exists. Can Med Assoc J (1979) 0.89
Natural history of left bundle-branch block. Br Heart J (1980) 0.89
Effect of cAMP on choline uptake and phosphatidylcholine biosynthesis in cultured chick heart cells. Biochem Cell Biol (1988) 0.87
Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects. Br Med J (1980) 0.86
Prognostic factors in the survival of 1,484 stroke cases observed for 30 to 48 months. II. Clinical variables and laboratory measurements. Arch Neurol (1978) 0.85
Prognostic factors in the survival of 1,484 stroke cases observed for 30 to 48 months. I. Diagnostic types and descriptive variables. Arch Neurol (1978) 0.84
The effect of epidermal growth factor on chronotropic response in cardiac cells in culture. Biochem Biophys Res Commun (1987) 0.84
Long term changes in blood pressure and risk of cerebrovascular disease. Stroke (1978) 0.84
Congenital complete atrioventricular heart block. A 25 year follow-up study. Am J Cardiol (1972) 0.84
A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients. Dis Nerv Syst (1972) 0.84
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol (1986) 0.83
Relationship of blood pressure in 20-39-year-old men to subsequent blood pressure and incidence of hypertension over a 30-year observation period. Circulation (1982) 0.83
Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease. Can Med Assoc J (1980) 0.83
Evidence that height is an independent risk factor for coronary artery disease (the Manitoba Follow-Up Study). Am J Cardiol (1994) 0.82
Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes. Cell Signal (1997) 0.81
Electrocardiographic abnormalities in apparently healthy men and the risk of sudden death. Drugs (1984) 0.81
Blood pressure and body mass index patterns-a longitudinal study. J Chronic Dis (1977) 0.81
A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses. Acta Cardiol (1975) 0.81
Relationship of weight loss and cigarette smoking to changes in high-density lipoprotein cholesterol. Am J Clin Nutr (1981) 0.80
Natural history of marked left axis deviation (left anterior hemiblock). Am J Cardiol (1979) 0.80
Mathematical and mechanical modeling of stress-strain relationship of pericardium. Am J Physiol (1975) 0.80
Blood pressure characteristics of a select group of North American males, followed for 20 years. Can Med Assoc J (1972) 0.80
Comparison of angiotensin II type-1 and type-2 receptor antagonists on angiotensin II-induced IP3 generation in cardiomyocytes. Gen Pharmacol (1998) 0.80
Health beliefs as predictors of success of alternate modalities of smoking cessation: results of a controlled trial. J Behav Med (1986) 0.80
Change in risk factor and the development of chronic disease. A methodological illustration. J Chronic Dis (1977) 0.80
Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol (1977) 0.80
A randomized trial comparing smoking cessation programs utilizing behaviour modification, health education or hypnosis. Addict Behav (1984) 0.79
Relationship of various QRS indices to SGOT levels in acute anterior myocardial infarction. Acta Cardiol (1977) 0.79
Angiotensin II-induced protein phosphorylation in the hypertrophic heart of the Dahl rat. Hypertension (1992) 0.79
HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridization. Genet Med (2001) 0.79
Autoimmunity to a 28-30 kD cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD). Clin Exp Immunol (1991) 0.79
Beneficial effects of streptokinase on left ventricular function after myocardial reoxygenation and reperfusion following global ischemia in the isolated rabbit heart. J Cardiovasc Pharmacol (1984) 0.78
Nutrition therapy in non-insulin-dependent diabetes mellitus. Diabetes Care (1981) 0.78
A classification of ventricular ectopic beats. J Electrocardiol (1982) 0.78
Predictors of outcome in a risk factor intervention trial using behavior modification. Prev Med (1982) 0.78
Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias. Am J Cardiol (1986) 0.78
The relationship of marked left axis deviation to the risk of ischemic heart disease. Int J Cardiol (1981) 0.77
Interphase cytogenetics of renal cortical neoplasms. Correlation with DNA ploidy by flow cytometry. Am J Clin Pathol (1995) 0.77
Antiarrhythmic effects of cyclic guanosine 3' :5'-monophosphate and sodium nitroprusside on barium chloride arrhythmias in rabbits. Arch Int Pharmacodyn Ther (1982) 0.77
Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial. Can J Cardiol (1987) 0.77
Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes. Peptides (2000) 0.76
Measurement of creatine kinase Z in human sera using a DEAE-cellulose mini-column method. Clin Chim Acta (1977) 0.76
Hydraulic permeability of canine and human pericardium in vitro. Basic Res Cardiol (1981) 0.76
Thapsigargin enhances camptothecin-induced apoptosis in cardiomyocytes. Pharmacol Toxicol (1999) 0.76
Regulation by angiotensin II of phosphate transport in cardiac myocytes. Biochem Pharmacol (1991) 0.76
Increased cardiac ppENK mRNA in cardiac hypertrophy and effects on blood pressure of its peptide products. Am J Physiol (1997) 0.76
Reversal of angiotensin II effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy. Cardiovasc Res (1991) 0.76
Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A control clinical trial. Atherosclerosis (1984) 0.76
Mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase in sera of patients after myocardial infarction. Clin Chim Acta (1984) 0.76
Prenatal sonographic appearance of Beare-Stevenson cutis gyrata syndrome: two- and three-dimensional ultrasonographic findings. Prenat Diagn (2001) 0.76
Differences in pituitary expression of proopiomelanocortin in Dahl salt-resistant and salt-sensitive rats on a high salt diet. Can J Physiol Pharmacol (1996) 0.76
A randomized clinical trial comparing behavior modification and individual counseling in the nutritional therapy of non-insulin-dependent diabetes mellitus: comparison of the effect on blood sugar, body weight, and serum lipids. Diabetes Care (1983) 0.76
Poisoning by cantharides. Can Med Assoc J (1978) 0.75
Medical Aspects of Aircrew Selection. Can Med Assoc J (1942) 0.75
Treatment of chronic pulmonary disease. Can Med Assoc J (1980) 0.75